Back to search

Article

Using Patient iPSC-derived Retinal Pigment Epithelial Cells to Evaluate Differential Susceptibility to MEK Inhibitor-Associated Retinopathy

2026-04-14

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> Compare the effect of MEK inhibition on iPSC-derived retinal pigmental epithelial (RPE) cells generated from a patient who developed MEK inhibitor-Associated Retinopathy (MEKAR) versus a patient who did not develop retinopathy. <h4>Design</h4> Case-control <h4>Subjects</h4> Two female patients with Neurofibromatosis Type 1 who were treated with MEK inhibitors. One patient dev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6a0a0216-f3cc-505f-a925-2e64ae53ea75
DOI
10.64898/2026.04.11.717944
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Using Patient iPSC-derived Retinal Pigment Epithelial Cells to Evaluate Differential Susceptibility to MEK Inhibitor-Associated RetinopathyDOI 10.64898/2026.04.11.717944
Select a neighboring publication to make it the new centre.